Intravenous Infusions Plc (GHSE:IIL)
0.0800
0.00 (0.00%)
At close: Jun 2, 2026
Intravenous Infusions Market Cap
Intravenous Infusions has a market cap or net worth of 21.95 million as of June 3, 2026. Its market cap has increased by 7.63% in one year.
Market Cap
21.95M
Enterprise Value
31.70M
Revenue
9.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since December 17, 2015, Intravenous Infusions's market cap has increased from 18.13M to 21.95M, an increase of 21.09%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 21.95M | 60.00% |
| Dec 4, 2025 | 13.72M | - |
| Dec 22, 2023 | 13.72M | 6.02% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fan Milk | 1.55B |
| SIC Insurance | 978.23M |
| Trust Bank | 480.00M |
| Cocoa Processing Company | 244.57M |
| Clydestone Ghana | 69.36M |
| Mega African Capital | 51.73M |
| Dannex Ayrton Starwin | 34.75M |
| Hords | 12.64M |